期刊文献+

随访系统在冠心病介入患者健康管理中的应用 被引量:9

Health Management with Follow-up System for Patients post Percutaneous Coronary Intervention
在线阅读 下载PDF
导出
摘要 目的探讨智能随访系统在冠心病介入治疗术后健康管理中的应用价值。方法老年心内科完成冠心病介入治疗的患者100例,分为对照组(n=50)和智能随访组(n=50)。观察两组服药依从性、冠心病危险因素知晓率。结果随访6个月、1年时,对照组抗血小板药物、他汀类药物使用率下降(P<0.05),智能随访组无显著性差异(P>0.05)。随访1年时,智能随访组对吸烟、高血压、高血糖、高血脂、肥胖等危险因素的知晓率较入院时显著提高(P<0.001),对照组无显著性差异(P>0.05)。结论利用智能随访系统对冠心病介入治疗术后患者进行临床宣教和干预指导,能提高患者服药依从性和对健康知识的知晓率。 Objective To investigate the application of Follow-up System in health management for the patients after percutaneous coro- nary intervention (PCI). Methods 100 patients underwent PCI were divided into study group (n=50) and control group (n=50). The control group received routine follow-up and the study group was followed up with the direction of Follow-up System. The incidence of adherence to medication after discharge and awareness of risks of coronary heart disease were recorded 6 and 12 months after discharge. Results The incidence of adherence to medication decreased in the control group (P〈0.05) after discharge, but was stable in the study group (P〉0.05). Awareness of risks of coronary heart disease increased in the study group 12 months after discharge (P〈0.01), but was stable in the control group (P〉0.05). Conclusion Follow-up System may help to improve the compliance and awareness in health management in the patients af- ter PCI.
出处 《中国康复理论与实践》 CSCD 北大核心 2013年第4期398-400,共3页 Chinese Journal of Rehabilitation Theory and Practice
关键词 冠状动脉性心脏病 经皮冠状动脉介入 健康管理 随访系统 依从性 知晓 coronary artery disease percutaneous coronary intervention health management Follow-up System compliance aware-ness
  • 相关文献

参考文献8

二级参考文献24

  • 1胡大一,孙艺红.优化的药物治疗是冠心病二级预防的基石[J].中华内科杂志,2007,46(6):442-443. 被引量:42
  • 2[1]National cholesterol education program exper panel.Executive summary of the third report of the national cholesterol education program(NCEP) expert panel on detection,evaluation,and treatment of high blood cholesterol in adults(adult treatment panel Ⅲ)[J].JAMA,2001,285:2486-2497.
  • 3[4]Kreisberg RA.Diabetic dyslipidemia[J].Am J Cardio,1998,82(12A):67-73.
  • 4[5]Stamler J,Vaccaro O,Neaton JD,et al.Diabetes,other risk factor and 12-y cardiovascular mortality for men screened in the multiple risk factor intervention trial[J].Diabetes Care,1993,16:434-444.
  • 5[6]Lamarche B,Tchernof A,Moorjanic S,et al.Small,dense low-density lipoprotein particlesasa predict or of the risk of ischemic heart disease in men[J].Circulation,1997,95:69-75.
  • 6[7]Erkelen W.Diabetic dyslipidaemia[J].Eur-Heart-J,1998,19(Suppl):27-40.
  • 7[8]Haffner SM.Epidemiology of insulin resistance and its relation to coronaryartery disease[J].Am J Cardiol,1999,84(1A):11.
  • 8[9]Nordt TK,Bode C.Endothelium and endogenous fibrinolysis[J].Z Kardiol,2000,89(3):219-226.
  • 9[10]Yudkin JS.Significance of classical and new risk factors in non-insulin dependent diabetes mellitus[J].J Diabetes Com Plications,1997,11(2):100-103.
  • 10[11]Stehouwer CAD,Nauta JJP,Zeldenrust GC,et al.Urinary albumi excretion,cardiovascular disease,non-insulin-depent diabetes mellitus[J].Lancet,1992,41(S):86-91.

共引文献87

同被引文献91

引证文献9

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部